凯赛生物：累计回购约55万股占比0.0941%

每日经济新闻2023-10-31

凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2379198955?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-10-31 17:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2379198955","market":"sh","top_or_hot":-1,"title":"凯赛生物：累计回购约55万股 占比0.0941%","media":"每日经济新闻","content":"<div>\n<p>凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>凯赛生物：累计回购约55万股 占比0.0941%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n凯赛生物：累计回购约55万股 占比0.0941%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-31 17:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0208","symbol_name":"化学纤维","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b","article_id":"2379198955","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2379198955","pubTimestamp":1698745056,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。截至发稿，凯赛生物市值为310亿元。文章来源：每日经济新闻原标题：凯赛生物：累计回购约55万股，占比0.0941%","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688065":"凯赛生物","BK0208":"化学纤维","GYRE":"Gyre Therapeutics"},"translate_title":"Kaisai Bio: The accumulated repurchase of about 550,000 shares accounted for 0.0941%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688065":0.9,"CBIO":0.9,"GYRE":0.9},"content_text":"凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。截至发稿，凯赛生物市值为310亿元。文章来源：每日经济新闻原标题：凯赛生物：累计回购约55万股，占比0.0941%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2379198955"}

凯赛生物：累计回购约55万股 占比0.0941%

精彩评论

凯赛生物：累计回购约55万股占比0.0941%